Sophia Genetics SA (SOPH) Social Stream
SOPHIA GENETICS SA (SOPH) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SOPH.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-16 | 3 | $24 | $23 | $23.5 | $5.5 | 327.27% |
| 2021-11-11 | 3 | $23 | $23 | $23 | $5.5 | 318.18% |
| 2022-02-15 | 3 | $23 | $18 | $20.5 | $5.5 | 272.73% |
| 2022-03-17 | 3 | $40.5 | $17 | $28.75 | $5.5 | 422.73% |
| 2022-04-12 | 3 | $18.001 | $17 | $17.5 | $5.5 | 218.18% |
| 2022-08-10 | 3 | $13 | $12 | $12.5 | $5.5 | 127.27% |
| 2022-11-08 | 3 | $12 | $12 | $12 | $5.5 | 118.18% |
| 2023-01-03 | 4 | $12 | $6 | $10 | $5.5 | 81.82% |
| 2023-03-08 | 4 | $12 | $6 | $9.666 | $5.5 | 75.75% |
| 2023-05-15 | 4 | $10 | $6 | $8.666 | $5.5 | 57.56% |
| 2023-08-08 | 4 | $10.001 | $6 | $8.667 | $5.5 | 57.58% |
| 2023-11-13 | 3 | $10 | $6 | $8 | $5.5 | 45.45% |
| 2023-11-29 | 4 | $10 | $6 | $8 | $5.5 | 45.45% |
The Trend in the Analyst Price Target
Over the past 19 months, SOPH's average price target has gone down $5.
SOPH reports an average of 127.55% for its upside potential over the past 38 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-08 | 4 | 12.000 | 6 | 9.666 | 3.08 | 213.83% |
| 2023-05-10 | 4 | 10.000 | 6 | 8.666 | 4.63 | 87.17% |
| 2023-05-15 | 4 | 10.000 | 6 | 8.666 | 4.46 | 94.3% |
| 2023-07-05 | 4 | 10.001 | 6 | 8.667 | 4.33 | 100.16% |
| 2023-11-29 | 4 | 10.000 | 6 | 8.000 | 4.11 | 94.65% |
SOPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.38 | 2 | 2 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
SOPH's average broker recommendation rating worsened by 0.17 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SOPHIA GENETICS SA's number of analysts covering the stock is greater than 163.65% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, SOPHIA GENETICS SA's variance in analysts' estimates is lower than -581.99% of them.
- SOPHIA GENETICS SA's upside potential (average analyst target price relative to current price) is higher than 1472.8% of all US stocks.
- In terms of how SOPHIA GENETICS SA fares relative to Healthcare stocks, note that its average analyst price target is higher than 473.19% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SOPHIA GENETICS SA are CADL, ICVX, and OMGA.
View All Top Stocks by Price Target
Is SOPH a Buy, Hold or Sell? See the POWR Ratings now!